Dattolo Pietro, Allinovi Marco, Iatropoulos Paraskevas, Michelassi Stefano
Nephrology and Dialysis Unit, S M Annunziata Hospital, Firenze, Italy.
BMJ Case Rep. 2013 May 27;2013:bcr2013009543. doi: 10.1136/bcr-2013-009543.
Wilms' tumour suppressor gene-1 (WT1) plays a critical role in kidney development and function. Several WT1 mutations can occur in exons 7, 8 and 9 and they have been associated with Denys-Drash syndrome. WT1 mutations of intron 9 have been reported too and associated with Frasier syndrome. However, overlapping and incomplete forms of both the syndromes have been described. We report a novel sequence variant (c.1012A>T) of the WT1 gene in exon 6 (p.R338X) in a 18-year-old girl with a history of Wilms' tumour, minor gonadal changes and relatively late-onset nephropathy. WT1-related nephropathies should be suspected in every patient with proteinuria not associated to immunological changes when a congenital neoplasia or minor gonadal anomalies are present.
威尔姆斯肿瘤抑制基因1(WT1)在肾脏发育和功能中起关键作用。外显子7、8和9可发生多种WT1突变,这些突变与迪尼-德拉斯综合征相关。也有报道称内含子9的WT1突变与弗雷泽综合征相关。然而,两种综合征都有重叠和不完全的形式。我们报告了一名18岁女孩的WT1基因外显子6(p.R338X)的一种新型序列变异(c.1012A>T),该女孩有威尔姆斯肿瘤病史、轻微性腺变化和相对晚发的肾病。当存在先天性肿瘤或轻微性腺异常时,对于每一位蛋白尿与免疫变化无关的患者,都应怀疑患有WT1相关肾病。